跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pethidine-hameln Solution for Injection 50mg/ml - HSA Drug Approval Details
Approvals
/
HSA
/
Pethidine-hameln Solution for Injection 50mg/ml
Approved
THERAPEUTIC
Pethidine-hameln Solution for Injection 50mg/ml
Siegfried Hameln GmbH (GERMANY)SANECA PHARMACEUTICALS A.S. (SLOVAK REPUBLIC)
🇸🇬 Health Sciences Authority
Approval Date
Nov 14, 2014
Approval ID
0f85508c3aaf84df
Company
Siegfried Hameln GmbH (GERMANY)SANECA PHARMACEUTICALS A.S. (SLOVAK REPUBLIC)
Type
Therapeutic
Approval Details
Approval Id
0f85508c3aaf84df
Drug Name
Pethidine-hameln Solution for Injection 50mg/ml
Product Name
Pethidine-hameln Solution for Injection 50mg/ml
Approval Number
SIN14662P
Approval Date
2014-11-14
Registrant
ZYFAS PHARMA PTE LTD
Licence Holder
ZYFAS PHARMA PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULAR
Atc Code
N02AB02
Atc Item Name
pethidine
Pharma Manufacturer Name
ZYFAS PHARMA PTE. LTD.
Company Detail Path
/organization/zyfas-pharma-pte-ltd
Active Ingredients
Pethidine 43.57mg as Pethidine Hydrochloride
50mg
PETHIDINE 43.57 MG AS PETHIDINE HYDROCHLORIDE
50 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Nov 14, 2014
Approval ID
0f85508c3aaf84df
Type
Therapeutic
Back to HSA Approvals
